Stephen D Brown, MD | |
1034 N 500 W, Provo, UT 84604-3380 | |
(801) 373-7850 | |
Not Available |
Full Name | Stephen D Brown |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 28 Years |
Location | 1034 N 500 W, Provo, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336185784 | NPI | - | NPPES |
870284448SDB | Other | UT | EMIA |
747190 | Other | UT | DMBA |
870284448008 | Medicaid | UT | |
107038403101 | Other | UT | IHC |
59035791200001 | Other | UT | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0204X | Radiology - Vascular & Interventional Radiology | 5903579-1205 (Utah) | Secondary |
2085R0202X | Radiology - Diagnostic Radiology | 5903579-1205 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Utah Valley Hospital | Provo, UT | Hospital |
American Fork Hospital | American fork, UT | Hospital |
Heber Valley Hospital | Heber city, UT | Hospital |
Park City Hospital | Park city, UT | Hospital |
Sanpete Valley Hospital - Cah | Mount pleasant, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Utah Valley Radiology Associates Inc | 1759286990 | 34 |
Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Biota Holdings Limited today announced that Daiichi Sankyo has received approval to manufacture and market Inavir® in Japan. Inavir® is Daiichi Sankyo's brand of laninamivir octanoate and also previously known as CS-8958. The approved indication is for the treatment of influenza in adults and children.
In a paper published in today's online issue of the Journal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease.
Acadia Healthcare Company, Inc. today announced a public offering of 8,333,333 shares of its common stock, pursuant to a registration statement filed with the Securities and Exchange Commission.
On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder.
News outlets report on what's at stake in terms of politics and policies when the Supreme Court issues its health law decision.
› Verified 7 days ago
Entity Name | Ihc Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Biota Holdings Limited today announced that Daiichi Sankyo has received approval to manufacture and market Inavir® in Japan. Inavir® is Daiichi Sankyo's brand of laninamivir octanoate and also previously known as CS-8958. The approved indication is for the treatment of influenza in adults and children.
In a paper published in today's online issue of the Journal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease.
Acadia Healthcare Company, Inc. today announced a public offering of 8,333,333 shares of its common stock, pursuant to a registration statement filed with the Securities and Exchange Commission.
On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder.
News outlets report on what's at stake in terms of politics and policies when the Supreme Court issues its health law decision.
› Verified 7 days ago
Entity Name | Utah Valley Radiology Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265483598 PECOS PAC ID: 1759286990 Enrollment ID: O20031202000093 |
News Archive
Biota Holdings Limited today announced that Daiichi Sankyo has received approval to manufacture and market Inavir® in Japan. Inavir® is Daiichi Sankyo's brand of laninamivir octanoate and also previously known as CS-8958. The approved indication is for the treatment of influenza in adults and children.
In a paper published in today's online issue of the Journal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease.
Acadia Healthcare Company, Inc. today announced a public offering of 8,333,333 shares of its common stock, pursuant to a registration statement filed with the Securities and Exchange Commission.
On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder.
News outlets report on what's at stake in terms of politics and policies when the Supreme Court issues its health law decision.
› Verified 7 days ago
Entity Name | St. George Radiology Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790736130 PECOS PAC ID: 7214838747 Enrollment ID: O20040117000167 |
News Archive
Biota Holdings Limited today announced that Daiichi Sankyo has received approval to manufacture and market Inavir® in Japan. Inavir® is Daiichi Sankyo's brand of laninamivir octanoate and also previously known as CS-8958. The approved indication is for the treatment of influenza in adults and children.
In a paper published in today's online issue of the Journal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease.
Acadia Healthcare Company, Inc. today announced a public offering of 8,333,333 shares of its common stock, pursuant to a registration statement filed with the Securities and Exchange Commission.
On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder.
News outlets report on what's at stake in terms of politics and policies when the Supreme Court issues its health law decision.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Stephen D Brown, MD 560w 800 N, Orem, UT 84057-3746 Ph: (801) 225-6246 | Stephen D Brown, MD 1034 N 500 W, Provo, UT 84604-3380 Ph: (801) 373-7850 |
News Archive
Biota Holdings Limited today announced that Daiichi Sankyo has received approval to manufacture and market Inavir® in Japan. Inavir® is Daiichi Sankyo's brand of laninamivir octanoate and also previously known as CS-8958. The approved indication is for the treatment of influenza in adults and children.
In a paper published in today's online issue of the Journal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease.
Acadia Healthcare Company, Inc. today announced a public offering of 8,333,333 shares of its common stock, pursuant to a registration statement filed with the Securities and Exchange Commission.
On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder.
News outlets report on what's at stake in terms of politics and policies when the Supreme Court issues its health law decision.
› Verified 7 days ago
Dr. Daniel Lyman Corey, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-225-6246 Fax: 801-225-1525 | |
Samuel Lynn Southam, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-357-7850 Fax: 801-357-7626 | |
Scott D Valadez, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Suite 112, Provo, UT 84604 Phone: 801-812-4624 Fax: 801-812-4699 | |
Mark S Asay, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-373-7850 | |
Dr. Derek Scott Bergeson, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Attn Credentialing, Provo, UT 84604 Phone: 801-354-8225 Fax: 801-418-0941 | |
Dalton H Wright, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Suite 112, Provo, UT 84604 Phone: 801-812-4624 Fax: 801-812-4699 | |
John S Collins, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-373-7850 |